This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Denke, M. A. Search for Related Content PubMed PubMed Citation Articles by Denke, M. A. Related Collections Health policy and outcome research Lipid and lipoprotein metabolism

(Circulation. 2005;112:3368-3370.)
© 2005 American Heart Association, Inc.

Editorial

Weighing in Before the Fight

Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol Versus Apolipoprotein B as the Best Predictor for Coronary Heart Disease and the Best Measure of Therapy

Margo A. Denke, MD

From the University of Texas Health Science Center at San Antonio, San Antonio, Tex.

Correspondence to Margo A. Denke, MD, 710 Water Street Suite 604, Kerrville, TX 78028. E-mail mdenke@ktc.com

Key Words: Editorials • cholesterol • lipids • lipoproteins • patients

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
In this issue of Circulation, Pischon and colleagues¹ present provocative data pitting the power of non–high-density lipoprotein cholesterol (non-HDL-C) versus apolipoprotein (apo) B to predict coronary heart disease (CHD) development in healthy men. They conclude not only that apoB is a superior predictor of CHD risk but, in addition, that "the practical application of our findings would be the substitution of apoB for LDL-C and non-HDL-C for screening and treatment of CHD risk."

Article p 3375

The article presents a healthy spar—a bob and weave—between apoB and the cholesterol concentrations in apoB-containing lipoproteins. The contenders could be fraternal twins because they are strikingly similar. They may be conjoined, making any competition between parts more akin to self-mutilation. This coveted prize must be earned by more than a simple sparring competition.

	Round 1: Reliability and Reproducibility of Assays

 
Guidelines for lipid management are not valuable unless the measurement of the indicator variable can be made reliably and reproducibly. The present standards for total cholesterol (TC) and HDL-C are a bias 3% and 5% (accuracy) with a coefficient of variation (CV) 3% and 4% (precision) with a total error of 8.9% and 13%, respectively.²

Before the mid-1980s, CVs for apoB averaged 30%. The development of standardized methods and suitable reference standards has led to marked improvements in reliability with an average bias of 2.1% (range –5.0 to 3.8%) and an average CV of 2.6% (range 0.9 to 5.1%).³ These appear to be comparable to that expected for non-HDL-C derived from TC and HDL-C measurements.

Round 1 Score: 10:10
Both are reliable measurements.

	Round 2: Biological Variation

 
. . . [Full Text of this Article]

This article has been cited by other articles:

				P. Y. Hsue, K. Squires, A. F. Bolger, B. Capili, G. A. Mensah, Z. Temesgen, C. A. Wanke, D. A. Wohl, and for Working Group 4 Screening and Assessment of Coronary Heart Disease in HIV-Infected Patients Circulation, July 8, 2008; 118(2): e41 - e47. [Full Text] [PDF]

				M. L. Fernandez and D. Webb The LDL to HDL Cholesterol Ratio as a Valuable Tool to Evaluate Coronary Heart Disease Risk J. Am. Coll. Nutr., February 1, 2008; 27(1): 1 - 5. [Abstract] [Full Text] [PDF]

				K.-L. Chien, H.-C. Hsu, T.-C. Su, M.-F. Chen, Y.-T. Lee, and F. B. Hu Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese J. Lipid Res., November 1, 2007; 48(11): 2499 - 2505. [Abstract] [Full Text] [PDF]

				E. Ingelsson, E. J. Schaefer, J. H. Contois, J. R. McNamara, L. Sullivan, M. J. Keyes, M. J. Pencina, C. Schoonmaker, P. W. F. Wilson, R. B. D'Agostino, et al. Clinical Utility of Different Lipid Measures for Prediction of Coronary Heart Disease in Men and Women JAMA, August 15, 2007; 298(7): 776 - 785. [Abstract] [Full Text] [PDF]